A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

Recruiting now · Phase 3

Conditions studied: Tophaceous Gout

In brief

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with tophaceous gout.

Key facts

Study ID
NCT07089888
Run by
Crystalys Therapeutics
People needed
250
Starts
2025-08-04
Expected to finish
2027-12-31
Last updated by the study team
2026-07-30

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.